检索

搜索所有类别
高级过滤器
关键词	删除

搜索类别
作者
标题
摘要
全文
搜扫PDF文档
补充文件
日期
从
到
索引项目
学科
类型 (method/approach)
覆盖
所有索引词字段

期

标题

作者

卷 16, 编号 3 (2014)

Avastin in clinical chemotherapy of malignant tumors

Gorbunova V.

卷 26, 编号 4 (2024)

Interim results analysis of the PERFECTION observational study in patients with metastatic non-small cell lung cancer

Laktionov K., Fedyanin M., Stroyakovskiy D., Mochalova A., Iasieva A., Fadeeva N., Shapovalova I., Mironov O., Dergunov A., Orlov S., Vasilev L., Bobrova E., Orlova S., Kosukhina A., Polshina N., Vardanian S., Fedoseev A., Tumasian K., Danilova A., Krashikhina T., Tsygankova E., Staritsyn D., Toporkova O., Boskhomdzhieva M., Sultanbaev A., Edamenko M., Dmitriev V., Shkradiuk A., Shkret K., Prosianikova O., Svechnikov E., Grigorchuk S.

(Eng)

卷 23, 编号 3 (2021)

Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives

Yudin D., Laktionov K., Laktionova L., Breder V.

(Rus)

卷 15, 编号 1 (2013)

Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies

Kit O., Vladimirova L., Sholokhova E.

卷 21, 编号 3 (2019)

Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer

Reutova E., Laktionov K., Iudin D., Neliubina L., Gorokhova G., Egorova A.

卷 11, 编号 4 (2009)

Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta

Orlov S., Dvorakovskaya I., Mosin I., Stel'makh L., Gorokhov A., Martynenko O., Poltoratskiy A.

卷 25, 编号 1 (2023)

Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials

Tcherkassova J., Prostyakova A., Tsurkan S., Suganov N., Boroda A., Zhilenkova A., Pirogova J., Sangadzhieva Z., Rusanov A., Rozhkov A., Fatyanova A., Nikitina N., Bagmet N., Sekacheva M.

(Rus)

卷 20, 编号 3 (2018)

Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo

Novikov D., Polotskiy B., Bogush T., Davidov M., Ahmedov B., Rotobelskaya L.

(Rus)

卷 23, 编号 3 (2021)

Malignant neoplasm of the bronchi and lung: Russian clinical guidelines

Laktionov K., Artamonova E., Borisova T., Breder V., Bychkov I., Vladimirova L., Volkov N., Ergnian S., Zhabina A., Kononets P., Kuz’minov A., Levchenko E., Malikhova O., Marinov D., Miller S., Moiseenko F., Mochal’nikova V., Novikov S., Pikin O., Reutova E., Rodionov E., Sakaeva D., Semenova A., Smolin A., Sotnikov V., Tuzikov S., Turkin I., Tiurin I., Chkhikvadze V., Kolbanov K., Chernichenko A., Fedenko A., Filonenko E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T., Butenko A., Gil’mutdinova I., Gridneva I., Eremushkin M., Zernova M., Kasparov B., Kovlen D., Kondrat’eva K., Konchugova T., Korotkova S., Krutov A., Obukhova O., Ponomarenko G., Semiglazova T., Stepanova A., Tkachenko G., Khulamkhanova M.

(Rus)

卷 24, 编号 3 (2022)

Malignant neoplasm of the bronchi and lung: Russian clinical guidelines

Laktionov K., Artamonova E., Borisova T., Breder V., Bychkov I., Vladimirova L., Volkov N., Ergnian S., Zhabina A., Kononets P., Kuzminov A., Levchenko E., Malikhova O., Marinov D., Miller S., Moiseenko F., Mochal’nikova V., Novikov S., Pikin O., Reutova E., Rodionov E., Sakaeva D., Sarantseva K., Semenova A., Smolin A., Sotnikov V., Tuzikov S., Turkin I., Tyurin I., Chkhikvadze V., Kolbanov K., Chernykh M., Chernichenko A., Fedenko A., Filonenko E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T., Butenko A., Gil’mutdinova I., Gridneva I., Eremushkin M., Zernova M., Kasparov B., Kovlen D., Kondrat’eva K., Konchugova T., Korotkova S., Krutov A., Obukhova O., Ponomarenko G., Semiglazova T., Stepanova A., Khulamkhanova M.

(Rus)

卷 23, 编号 4 (2021)

Targeted therapy of brain metastases in patients with ALK-positive non-small cell lung cancer: A review

Sakaeva D., Bulavina I.

(Rus)

卷 22, 编号 2 (2020)

Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma

Odintsova S., Sviridenko M., Cheremnykh A., Filippova E., Urtenova M., Orlov S.

(Rus)

卷 20, 编号 3 (2018)

The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156

Kuzminov A., Gorbunova V., Poddubskaya E., Bagrova S., Baranova M., Laktionov K.

(Rus)

卷 24, 编号 3 (2022)

The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis

Nasretdinov A., Menshikov K., Sultanbaev A., Musin S., Sultanbaeva N., Men'shikova I.

(Rus)

卷 22, 编号 3 (2020)

Detection of disseminated tumor cells and their relationship with a population of bone marrow lymphocytes in patients with non-small cell lung cancer

Djumanazarov T., Chulkova S., Tupitsyn N., Chernysheva O., Allakhverdiev A., Palladina A., Kupryshina N., Kolbatskaya O., Kononetz P., Akhmedov B., Gerasimov S.

(Rus)

卷 22, 编号 2 (2020)

Adjuvant targeted therapy for non-small cell lung cancer

Laktionov K., Kazakov A., Gordiev M., Kononets P., Akhmedov B., Maevskaia J.

(Rus)

卷 20, 编号 4 (2018)

Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy?

Dadyev I., Davydov M., Shogenov M., Abdullaev A., Ibraev M., Filatov A.

(Rus)

卷 19, 编号 1 (2017)

The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor

Ryazhenov V.

(Rus)

卷 23, 编号 2 (2021)

The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report

Ognerubov N., Antipova T.

(Rus)

卷 23, 编号 1 (2021)

Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data

Bogdanov A., Moiseenko F., Egorenkov V., Bogdanov A., Volkov N., Fedyanin M.

(Rus)

卷 20, 编号 2 (2018)

New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors

Laktionov K., Reutova E., Nelyubina L., Pitkevich M., Okruzhnova M., Ardzinba M., Yudin D., Demidova I., Zaretsky A.

(Rus)

卷 24, 编号 1 (2022)

Atezolizumab in the first-line treatment of metastatic non-small cell lung cancer. Clinical experience of the drug application. Case report

Ognerubov N., Antipova T.

(Rus)

卷 23, 编号 1 (2021)

Treatment of advanced small cell lung cancer. Clinical case and literature review

Menshikov K., Sultanbaev A., Musin S., Menshikova I., Nasretdinov A., Sultanbaeva N.

(Rus)

卷 22, 编号 3 (2020)

Prospects for the development of adjuvant therapy for non-small cell lung cancer

Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.

(Rus)

卷 18, 编号 3 (2016)

Tracheal and bronchial plastic resection in patients with lung cancer

Khvastunov R., Usachev A.

(Rus)

卷 15, 编号 4 (2013)

The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC

Orlov S.

卷 10, 编号 4 (2008)

Znachenie klinicheskikh i molekulyarno-geneticheskikh prediktorov otveta na terapiyu ingibitorami tirozinkinazy v vybore lechebnoy taktiki pri nemelkokletochnom rake legkogo

Smolin A., Konev A., Solovey T., Nikolaeva S., Shamanskaya Y.

卷 9, 编号 4 (2007)

Vliyanie immunomodulyatora Galavit na immunologicheskiy status bol'nykh nemelkokletochnym rakom legkogo II-III stadii

Vel'sher L., Gabuniya Z., Grishina T., Germanov A., Korobkova L., Platonov D., Argun V., Gens G.

卷 25, 编号 1 (2023)

Clinical case of complications of immunotherapy – encephalitis

Lyadova M., Kuchevskaya O., Kulikova E.

(Rus)

卷 24, 编号 1 (2022)

Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report

Orlov S., Baldin P., Diuzeva N., Krechetova A., Mordovskiy A., Moskovchenko A., Musaeva N., Romanchuk O.

(Rus)

卷 10, 编号 3 (2008)

Samoe masshtabnoe sravnitel'noe issledovanie III fazy iz vsekh ranee opublikovannykh pokazalo, chto IRESSATM (gefitinib) tak zhe effektivna, kak i dotsetaksel u patsientov s rasprostranennym nemelkokletochnym rakom legkogo posle neudachi predshestvuyushchey terapii

卷 26, 编号 2 (2024)

Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)

Editorial B.

(Rus)

卷 24, 编号 1 (2022)

Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"

Ryazhenov V., Orlov S., Ivakhnenko O.

(Rus)

卷 23, 编号 2 (2021)

Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report

Zhabina A., Moiseenko F., Volkov N., Abduloeva N., Moiseenko V.

(Rus)

卷 21, 编号 3 (2019)

Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice

Sakaeva D., Ruchkin V., Goncharova O., Abbasova R., Mufazalov F.

卷 21, 编号 2 (2019)

Lung cancer in the Tomsk region (epidemiological aspects)

Choynzonov E., Zhuikova L., Ananina O., Odintsova I., Pikalova L.

(Rus)

卷 16, 编号 2 (2014)

Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)

Kolbin A., Kurylev A., Pavlysh A., Proskurin M., Balykina Y.

卷 23, 编号 3 (2021)

Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis

Goryaynov S.

(Rus)

卷 20, 编号 3 (2018)

Differential diagnosis of lung cancer and tuberculosis: review

Belova O., Komarov I.

(Rus)

卷 16, 编号 3 (2014)

Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib

Smolin A., Gorbacheva A.

卷 15, 编号 3 (2013)

Gefitinib – terapiya vybora 1-y linii nemelkokletochnogo raka legkogo u bol'nykh s nalichiem mutatsiy v gene EGFR

Bolotina L.

卷 11, 编号 3 (2009)

Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo

Poddubnaya I.

卷 9, 编号 1 (2007)

Melkokletochnyy rak legkogo: chto izmenilos' za poslednie 30 let?

Bychkov M.

卷 23, 编号 3 (2021)

The modified biopsy technique conducting ultrasound bronchoscopy with endosonographic-guided position of the endoscopic instrument in the area of the pathological focus. The results of the first phase of the clinical trial

Pushkarev E., Vazhenin A., Kulaev K., Iusupov I., Zuikov K., Popova I.

(Rus)

卷 23, 编号 3 (2021)

Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features

Reutova E., Laktionov K.

(Rus)

卷 22, 编号 2 (2020)

Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer

Statsenko G., Kurakin V., Plokhotenko I.

(Rus)

卷 20, 编号 4 (2018)

Pneumonectomy with carinal resection in patients with non-small cell lung cancer: short and long-term results

Dadyev I., Davydov M., Abdullaev A., Kulik I., Ambalova Z., Akhmedov P., Anokhin A., Karasheva B.

(Rus)

卷 20, 编号 3 (2018)

The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer

Karabina E., Lubchenko L., Garunov A.

(Rus)

卷 19, 编号 2 (2017)

The treatment of patients with advanced lung cancer associated with EGFR mutation

Bolotina L.

(Rus)

卷 18, 编号 3 (2016)

Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene

Ryazhenov V., Gorokhova S.

(Rus)

1 - 50 的 50 信息

检索提示:

检索的名词区分大小写
常用字词将被忽略
默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
使用引号检索一个完整的词组; 例如： "open access publishing"
使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册

检索

高级过滤器

搜索类别

日期

索引项目

检索提示: